盐野义支持的Apnimed申请赴美IPO
2026-07-10 21:36:18
据彭博社报道，获日本盐野义制药支持的Apnimed Inc.已提交在美国首次公开募股(IPO)申请，以筹资推进其治疗阻塞性睡眠呼吸暂停的口服药物商业化。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
惠誉：沙特2026年实际GDP增速料放缓至0.6%Next article：
地缘政治 | 古巴本周第二次全国停电
